Weyco Group (WEYS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
The annual meeting is scheduled for May 5, 2026, to elect seven directors, ratify Deloitte & Touche LLP as auditor, and hold an advisory vote on executive compensation.
Only common stock is outstanding, with one vote per share; 9,531,214 shares are eligible as of March 13, 2026.
Proxy materials and the 2025 Annual Report are available online; proxies can be revoked before the meeting.
Voting matters and shareholder proposals
Shareholders will vote on electing seven directors, ratifying Deloitte as auditor for 2026, and approving executive compensation on a non-binding basis.
Board recommends voting FOR all director nominees and FOR both auditor ratification and say-on-pay.
Shareholder proposals for the 2027 meeting must be received by December 3, 2026.
Board of directors and corporate governance
Board consists of seven members, with a mix of executive and independent directors.
Four directors are independent per Nasdaq standards; all committees are composed solely of independent directors.
Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined responsibilities.
Board combines Chairman and CEO roles, with independent directors meeting separately.
Board diversity includes gender and ethnic representation, and a range of skills in leadership, finance, technology, and operations.
Latest events from Weyco Group
- Sales and earnings fell amid tariff-driven margin pressure, with Florsheim outperforming peers.WEYS
Q4 20254 Mar 2026 - Record Q2 net earnings and higher margins despite lower sales; outlook positive for H2.WEYS
Q2 20242 Feb 2026 - Sales and earnings declined, but gross margin rose and a $2 special dividend was declared.WEYS
Q3 202416 Jan 2026 - Record earnings despite lower sales; new tariffs and uncertainty to impact 2025.WEYS
Q4 202425 Dec 2025 - Director elections, auditor change, and annual say-on-pay highlight governance and oversight.WEYS
Proxy Filing2 Dec 2025 - Sales and earnings declined as 161% tariffs loom, but supply chain shifts and liquidity support resilience.WEYS
Q1 202525 Nov 2025 - Sales and earnings fell sharply in Q2 2025 amid tariffs and weak demand; outlook remains cautious.WEYS
Q2 202523 Nov 2025 - Tariffs pressured margins as Q3 sales and earnings fell, but a $2 special dividend was declared.WEYS
Q3 202513 Nov 2025